$0.04 EPS Expected for TripAdvisor, Inc. (TRIP); Profile of 6 Analysts Covering Spectrum Pharmaceuticals, Inc. (SPPI)

January 18, 2018 - By Marguerite Chambers

Among 6 analysts covering Spectrum Pharma (NASDAQ:SPPI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Spectrum Pharma had 11 analyst reports since August 7, 2015 according to SRatingsIntel. As per Thursday, August 27, the company rating was upgraded by Zacks. The stock has “Buy” rating by Jefferies on Friday, February 10. Jefferies maintained the shares of SPPI in report on Wednesday, June 7 with “Buy” rating. Jefferies maintained it with “Buy” rating and $18 target in Monday, October 9 report. The firm has “Outperform” rating given on Thursday, November 5 by RBC Capital Markets. Jefferies maintained it with “Buy” rating and $9.0 target in Thursday, August 24 report. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, August 16. The stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) earned “Outperform” rating by RBC Capital Markets on Friday, August 7. See Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) latest ratings:

18/12/2017 Broker: B. Riley & Co Rating: Buy New Target: $26 Initiates Coverage On
18/12/2017 Broker: FBR Capital Rating: Buy New Target: $26.0
24/10/2017 Broker: Guggenheim Rating: Buy New Target: $32 Initiates Coverage On
09/10/2017 Broker: Jefferies Rating: Buy Old Target: $13 New Target: $18 Maintain
24/08/2017 Broker: Jefferies Rating: Buy New Target: $9.0 Maintain
16/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $14 Reinitiate

Analysts expect TripAdvisor, Inc. (NASDAQ:TRIP) to report $0.04 EPS on February, 21.They anticipate $0.01 EPS change or 20.00% from last quarter’s $0.05 EPS. TRIP’s profit would be $5.56M giving it 223.63 P/E if the $0.04 EPS is correct. After having $0.23 EPS previously, TripAdvisor, Inc.’s analysts see -82.61% EPS growth. The stock decreased 0.33% or $0.12 during the last trading session, reaching $35.78. About 1.35 million shares traded. TripAdvisor, Inc. (NASDAQ:TRIP) has declined 30.31% since January 18, 2017 and is downtrending. It has underperformed by 47.01% the S&P500.

TripAdvisor, Inc. operates as an online travel company. The company has market cap of $4.97 billion. The firm operates through two divisions, Hotel and Non-Hotel. It has a 76.95 P/E ratio. The Company’s travel platform aggregates reviews and opinions of members about destinations, accommodations, activities and attractions, and restaurants, which enables users to research and plan their travel experiences, as well as book hotels, flights, cruises, vacation rentals, activities and attractions, and restaurant reservations.

Since August 17, 2017, it had 0 insider purchases, and 2 sales for $514,535 activity. Halpin Dermot had sold 12,859 shares worth $502,598 on Thursday, August 17. 346 shares were sold by Nishar Dipchand, worth $11,937.

Among 30 analysts covering TripAdvisor LLC (NASDAQ:TRIP), 0 have Buy rating, 7 Sell and 23 Hold. Therefore 0 are positive. TripAdvisor LLC had 78 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained TripAdvisor, Inc. (NASDAQ:TRIP) rating on Thursday, September 28. RBC Capital Markets has “Hold” rating and $38.0 target. RBC Capital Markets maintained the stock with “Sector Perform” rating in Friday, February 12 report. The rating was initiated by CLSA on Thursday, December 8 with “Underperform”. The firm has “Buy” rating given on Thursday, September 17 by Deutsche Bank. The stock of TripAdvisor, Inc. (NASDAQ:TRIP) earned “Equal-Weight” rating by Barclays Capital on Wednesday, November 8. On Wednesday, July 19 the stock rating was upgraded by Cowen & Co to “Market Perform”. The rating was maintained by Cowen & Co on Wednesday, September 27 with “Hold”. The firm has “Sell” rating given on Friday, May 26 by Macquarie Research. On Thursday, September 17 the stock rating was maintained by Piper Jaffray with “Overweight”. The rating was maintained by Jefferies with “Sell” on Thursday, September 28.

Investors sentiment increased to 0.94 in Q3 2017. Its up 0.15, from 0.79 in 2017Q2. It improved, as 37 investors sold TripAdvisor, Inc. shares while 108 reduced holdings. 52 funds opened positions while 84 raised stakes. 120.15 million shares or 5.11% more from 114.31 million shares in 2017Q2 were reported. Pitcairn stated it has 49,551 shares. Kentucky Retirement Systems has invested 0.02% in TripAdvisor, Inc. (NASDAQ:TRIP). Los Angeles Cap Management & Equity holds 0% or 15,854 shares in its portfolio. Norinchukin Retail Bank The owns 8,063 shares or 0.01% of their US portfolio. Benjamin F Edwards And Incorporated owns 265 shares. Aperio Ltd Com owns 26,119 shares for 0.01% of their portfolio. Boothbay Fund Mngmt Ltd Liability Co invested 0.06% of its portfolio in TripAdvisor, Inc. (NASDAQ:TRIP). American Int Group Incorporated stated it has 35,089 shares or 0.01% of all its holdings. Banque Pictet And Cie reported 0.01% stake. Advantus Cap accumulated 10,676 shares. Quantitative Ltd Company invested in 29,500 shares. Tci Wealth Advsr Inc stated it has 39 shares or 0% of all its holdings. Moreover, Ingalls Snyder has 0.01% invested in TripAdvisor, Inc. (NASDAQ:TRIP) for 6,509 shares. Atlantic Trust Group Inc holds 53,888 shares or 0.01% of its portfolio. Gateway Inv Advisers Lc reported 0% stake.

Investors sentiment increased to 2.84 in 2017 Q3. Its up 1.89, from 0.95 in 2017Q2. It improved, as 13 investors sold Spectrum Pharmaceuticals, Inc. shares while 19 reduced holdings. 38 funds opened positions while 53 raised stakes. 71.60 million shares or 29.39% more from 55.33 million shares in 2017Q2 were reported. Teachers Retirement Of The State Of Kentucky, a Kentucky-based fund reported 13,500 shares. Los Angeles Capital & Equity Research holds 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 12,560 shares. Vantage Inv Advsrs Ltd owns 200 shares or 0% of their US portfolio. Comerica Natl Bank holds 82,522 shares or 0.01% of its portfolio. Financial Bank Of America Corporation De owns 0% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 338,612 shares. Citigroup, New York-based fund reported 107,367 shares. 61,452 were reported by . Mason Street Limited Liability Company invested 0.01% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Citadel Advsr Ltd Liability Co reported 82,514 shares. Ameritas Invest stated it has 6,050 shares. Virginia Retirement Et Al reported 27,900 shares. Northern Tru stated it has 987,290 shares or 0% of all its holdings. Capital One National Association has invested 0.02% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Denver Invest Advsrs Ltd Liability has 0.01% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). 37,513 are owned by Voya Investment Mgmt Lc.

The stock decreased 0.98% or $0.19 during the last trading session, reaching $19.22. About 157,191 shares traded. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has declined 20.03% since January 18, 2017 and is downtrending. It has underperformed by 36.73% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts